As stated in a recently published information by Credence Research, “Parenteral Nutrition industry Growth, Future Prospects and Competitive Analysis, 2016-2022,” the global parenteral nutrition industry was valued at USD 4,553.2 Mn in 2015, and is expected to reach USD 6,638.0 Mn by 2022, expanding at a CAGR of 5.5% from 2016 to 2022.

Industry Insights:

The global parenteral nutrition industry is anticipated to cross the 6 Bn mark by 2022. Growing prevalence of malnutrition and chronic conditions along with escalation in the geriatric population pool have key impact on driving this industry. Additionally, perpetual growth in birth rates and premature births will also further support the growth of this industry. Growing awareness about parenteral nutrition through government and non-profit channels has allowed growth in demand for clinical nutrition in the global patient population, and consequently parenteral nutrition products.

High prevalence of chronic condition such as cancer is expected to promote the use of parenteral nutrition through chemotherapy sessions since this treatment mode leads to critical loss of nutrition, appetite and energy. Parenteral nutrition efficiently addresses these issues in chemotherapy patients and patients with other chronic conditions where oral nutrition is not possible or is not sufficient. Parenteral nutrition effectively overcomes the risk of dietary imbalance thus adding to growth in its demand. However, being an invasive process, risks of infection during administration and informationing of such instances may hold back the growth of this industry to a minor extent.

Browse the full information Parenteral Nutrition: industry Growth, Future Prospects and Competitive Analysis, 2016-2022 information at

Request For Sample :

North America and Europe together take approximately 45% of the global industry share. Introduction of novel parenteral nutrition solutions for pediatric patient group is the most prominent trend in this industry. Products for geriatric patient group are also in high demand corresponding to the growth in number of this population group. Asia-Pacific and Middle East and Africa are the fastest growing regional industrys for parenteral nutrition products. High prevalence of malnutrition is the key driver for parenteral nutrition industry in these regions. The number of low- and middle-income countries in Asia-Pacific and Middle East and Africa is high as against other parts of the world. Moreover, it is observed that the informationed malnutrition during pregnancy and in children demonstrate higher numbers in Middle East and Africa. Based on such factors organizations such as the UN and local governments have initiated intensive awareness and aid programs to overcome the issue of malnutrition and associated mortality.

Expansion of product portfolio through introduction of novel products is a key trend observed in the parenteral nutrition industry. Entry in untapped industrys of Asia-Pacific and Africa forms one of the major strategies of the global industry players. Some of the key players in the global parenteral nutrition industry include Grifols International SA, Otsuka Pharmaceutical Factory, B Braun Melsungen AG, Baxter International, Fresenius Kabi and others.

About Us:

Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US


Ph: 1-800-361-8290